Tom T. Shimabukuro

Best Publications

• Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

  Unknown

  1067
  Citations

• Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

  T.T. Shimabukuro;S.Y. Kim;T.R. Myers;P.L. Moro

  890
  Citations

• Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

  Tom T. Shimabukuro;Michael Nguyen;David Martin;Frank DeStefano

  627
  Citations

• Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

  Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  599
  Citations

• Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

  Julia W. Gargano;Megan Wallace;Stephen C. Hadler;Gayle Langley

  545
  Citations

• US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

  Isaac See;John R. Su;Allison Lale;Emily Jane Woo

  484
  Citations

• Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

  Unknown

  469
  Citations

• Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014

  Lisa A. Grohskopf;David K. Shay;Tom T. Shimabukuro;Leslie Z. Sokolow

  444
  Citations

• First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.

  Julianne Gee;Paige Marquez;John Su;Geoffrey M. Calvert

  402
  Citations

• Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

  Unknown

  325
  Citations

• COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021

  Unknown

  288
  Citations

• Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

  Unknown

  270
  Citations

• Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.

  Hannah G. Rosenblum;Stephen C. Hadler;Danielle Moulia;Tom T. Shimabukuro

  198
  Citations

• SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020

  Lakshmi Panagiotakopoulos;Tanya R Myers;Julianne Gee;Heather S Lipkind

  174
  Citations

• COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.

  Anne M. Hause;Julianne Gee;James Baggs;Winston E. Abara

  154
  Citations

• Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students—Iowa, 2006

  Unknown

  153
  Citations

• Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans

  Unknown

  143
  Citations

• Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases — United States, 2024

  Unknown

  110
  Citations

• The MMR Vaccine and Autism.

  Frank DeStefano;Tom T Shimabukuro

  102
  Citations

• Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.

  David K Shay;Tom T Shimabukuro;Frank DeStefano

  99
  Citations